Project Details
| Status | Active |
|---|---|
| Effective start/end date | 10/25/24 → … |
A Phase 1/2, First-in-Human Study of the Menin-KMT2A (MLL1) Inhibitor Bleximenib in Participants With Acute Leukemia
- Shah, Shilpan (PI)
- Abanonu, Chinemerem (Key Personnel)
- Ganguly, Siddhartha (Key Personnel)
- Guan, Jian (Key Personnel)
- Mai, Hanh P. (Key Personnel)
- Pingali, S. Ravi (Key Personnel)
Project: Clinical Trial